Loading...
Rosuvastatin Attenuates Myocardial Ischemia-Reperfusion Injury via Upregulating miR-17-3p-Mediated Autophagy
Myocardial diseases usually appear ischemic. Reperfusion therapy is one of the effective methods that can improve clinical therapeutic efficacy. However, reperfusion results in myocardial injury named I/R injury. Rosuvastatin (RS) is HMG-CoA reductase inhibitor. We investigated the role of RS in the...
Na minha lista:
| Udgivet i: | Cell Reprogram |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc., publishers
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6918854/ https://ncbi.nlm.nih.gov/pubmed/31730378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cell.2018.0053 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|